Reply to R.D. Nipp et al, M.-J. Molina-Garrido et al, and A. Gajra et al-Reference-Cited by-同舟云学术

Reply to R.D. Nipp et al, M.-J. Molina-Garrido et al, and A. Gajra et al

Published:2016-11-20 Issue:33 Volume:34 Page:4050-4051
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Corre Romain¹,Léna Hervé¹,Vergnenègre Alain¹,Chouaïd Christos¹

Affiliation:

1. Romain Corre, Hervé Léna, Centre Hospitalier Universitaire Pontchaillou de Rennes; and Institut National de la Santé et de la Recherche Médicale, Centre de Lutte Contre le Cancer Eugene Marquis, Rennes, France; Alain Vergnenègre, Centre Hospitalier Universitaire du Cluzeau de Limoges, Limoges, France; and Christos Chouaïd, Centre Hospitalier Intercommunal de Creteil, Creteil, France

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2016.69.1105

Reference5 articles.

1. Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non–Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study

2. First-Line Gefitinib for Patients With Advanced Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy

3. A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study)

4. A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study)

5. Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer